699 related articles for article (PubMed ID: 7830731)
1. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
[TBL] [Abstract][Full Text] [Related]
2. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
Salk J
Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
4. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.
Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A
Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.
Kohler KA; Banerjee K; Gary Hlady W; Andrus JK; Sutter RW
Bull World Health Organ; 2002; 80(3):210-6. PubMed ID: 11984607
[TBL] [Abstract][Full Text] [Related]
6. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
Strebel PM; Aubert-Combiescu A; Ion-Nedelcu N; Biberi-Moroeanu S; Combiescu M; Sutter RW; Kew OM; Pallansch MA; Patriarca PA; Cochi SL
Am J Epidemiol; 1994 Dec; 140(12):1111-24. PubMed ID: 7998593
[TBL] [Abstract][Full Text] [Related]
7. Poliomyelitis: 20 years--the Pondicherry experience.
Mahadevan S; Ananthakrishnan S; Srinivasan S; Nalini P; Puri RK; Badrinath S; Rao RS
J Trop Med Hyg; 1989 Dec; 92(6):416-21. PubMed ID: 2558226
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-associated paralytic poliomyelitis in the United States: no evidence of elevated risk after simultaneous intramuscular injections of vaccine.
Izurieta HS; Sutter RW; Baughman AL; Strebel PM; Stevenson JM; Wharton M
Pediatr Infect Dis J; 1995 Oct; 14(10):840-6. PubMed ID: 8584308
[TBL] [Abstract][Full Text] [Related]
9. Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis.
Kindberg E; Ax C; Fiore L; Svensson L
J Med Virol; 2009 May; 81(5):933-6. PubMed ID: 19319949
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.
Deivanayagam N; Nedunchelian K; Ahamed SS; Rathnam SR
Bull World Health Organ; 1993; 71(3-4):307-9. PubMed ID: 8324848
[TBL] [Abstract][Full Text] [Related]
11. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
12. Injections and poliomyelitis: what are the risks of vaccine associated paralysis?
Wyatt HV
Dev Biol Stand; 1986; 65():123-6. PubMed ID: 3549394
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular injections and vaccine-associated poliomyelitis.
Sepkowitz S
N Engl J Med; 1995 Jul; 333(1):64. PubMed ID: 7777003
[No Abstract] [Full Text] [Related]
14. Intramuscular injection as a provoking factor for paralysis in acute poliomyelitis. A case control study.
Deivanayagam N; Nedunchelian K; Ahamed SS; Ashok TP; Mala N; Ratnam SR
Indian Pediatr; 1993 Mar; 30(3):335-40. PubMed ID: 8365783
[TBL] [Abstract][Full Text] [Related]
15. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
Andrus JK; Strebel PM; de Quadros CA; Olivé JM
Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
[TBL] [Abstract][Full Text] [Related]
16. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
17. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
18. Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study.
Orstavik I; Flugsrud LB; Lahelle O
Bull World Health Organ; 1971; 45(6):733-9. PubMed ID: 4336552
[TBL] [Abstract][Full Text] [Related]
19. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
20. Paralytic syndromes in children: epidemiology and relationship to vaccination.
Zangwill KM; Yeh SH; Wong EJ; Marcy SM; Eriksen E; Huff KR; Lee M; Lewis EM; Black SB; Ward JI
Pediatr Neurol; 2010 Mar; 42(3):206-12. PubMed ID: 20159431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
